[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quantum Cyber N.V. (QUCY)

Quantum Cyber N.V. (QUCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Quantum Cyber N.V. 1501 BELVEDERE ROAD SUITE 500 WEST PALM BEACH FL 33406 DEU

https://quantum-cyber.ai Employees: 13 P: 561-562-4111

Sector:

Medical

Description:

Mainz Biomed N.V. develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. Mainz Biomed N.V. is based in BERKELEY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 35,919
Enterprise Value, $K 35,109
Shares Outstanding, K 14,661
Float, K 13,224
% Float 90.20%
Short Interest, K 10,531
Short Float 71.83%
Days to Cover 1.00
Short Volume Ratio 0.57
% of Insider Shareholders 9.80%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 540 K
Annual Net Income, $ -16,210 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,000 K
EBIT, $ -22,910 K
EBITDA, $ -22,290 K

Growth:

1-Year Return 23.62%
3-Year Return -98.76%
5-Year Return 0.00%
5-Year Revenue Growth 10.20%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.21 on 05/15/26
Next Earnings Date 08/21/26
Earnings Per Share ttm -47.60
EPS Growth vs. Prev Year -83.66%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 12/03/24

QUCY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -3,001.85%
Debt/Equity 0.13
Price/Sales 60.88
Price/Cash Flow N/A
Price/Book 6.13
Book Value/Share 0.07
Interest Coverage -42.81
60-Month Beta 2.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.